Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126051581 | 12605158 | 1 | I | 20160720 | 20160729 | 20160729 | EXP | JP-AMGEN-JPNSP2016095690 | AMGEN | 0.00 | Y | 0.00000 | 20160728 | MD | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126051581 | 12605158 | 1 | PS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 25 MG EVERY OTHER WEEK | U | 103795 | 25 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | ||||||
126051581 | 12605158 | 2 | SS | RHEUMATREX | METHOTREXATE SODIUM | 1 | Oral | 2MG CAPSULES AT UNKNOWN DOSE AND FREQUENCY | 0 | CAPSULE |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126051581 | 12605158 | 1 | Product used for unknown indication |
126051581 | 12605158 | 2 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126051581 | 12605158 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126051581 | 12605158 | Inappropriate schedule of drug administration | |
126051581 | 12605158 | Lymphoproliferative disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |